Intelligence · Clinical Development
Pipeline search results
Programs matching “healthy” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 1,124 pipeline programs matching "healthy" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
1mg KHK7580
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Healthy Volunteer
1 trial -
200 mg GLPG0634 as capsules, fasted
Lakefront Biotherapeutics NV
Healthy
1 trial -
2007-0001
Boehringer Ingelheim
Healthy volunteer trial
1 trial -
219728
GlaxoSmithKline
Healthy volunteers
1 trial -
24EU-Lip03
The George Institute
None. Healthy subjects
1 trial -
30 mg dexlansoprazole capsules manufactured at TOB
Takeda
Healthy Volunteers
2 trials -
300141
HALEON AUSTRALIA PTY LTD
Healthy volunteers, therapeutic indication not studied
1 trial -
5 mg/500 mg Glipizide Metformin Hydrochloride Tablets
Teva Pharma GmbH
Healthy
1 trial -
5 mg/500 mg METAGLIP™ Tablets
Teva Pharma GmbH
Healthy
1 trial -
500 mg GLPG1837 as oral suspension
Lakefront Biotherapeutics NV
Healthy
1 trial -
600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mL
Teva Pharma GmbH
Healthy
2 trials -
626
Jian Li
Healthy Subjects (HS)
1 trial -
626
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Healthy Subjects (HS)
1 trial -
627
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Healthy Subjects (HS)
1 trial -
63733657EDI1003
Janssen-Cilag International N.V.
Alzheimer's Disease (Healthy Participants)
1 trial -
67953964MDD1010
Janssen-Cilag International N.V.
Healthy Adult Participants
1 trial -
67953964MDD1011
Janssen-Cilag International N.V.
Healthy Adult Participants.
1 trial -
845900241/0147/1
Lacuna Pharma Pty Ltd
Not applicable (submitted trial is a bioavailability study in healthy subjects)
1 trial -
974/24
Alphapharm Pty Ltd
Bioequivalence study in healthy volunteers under fasting conditions
1 trial -
987/24
Lacuna Pharma Pty Ltd
Not applicable (submitted trial is a bioavailability study in healthy subjects).
1 trial -
988/24
Lacuna Pharma Pty Ltd
Not applicable (submitted trial is a bioavailability study in healthy subjects).
1 trial -
A Mass Balance Study of [14C]-IPN60250 in Healthy Adult Participants
Ipsen
Primary sclerosing cholangitis (PSC)
1 trial -
A Multiple-Ascending-Dose Study of MK-1708 in Healthy Participants
Merck Sharp and Dohme
Amyotrophic lateral sclerosis and Alzheimer’s disease
1 trial -
A Single-Ascending-Dose Study of MK6916 in Healthy Participants
Merck Sharp and Dohme
Acute and chronic Pain
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.